2002
Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program
Vertefeuille J, Strathdee S, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program. Journal Of Drug Issues 2002, 32: 1125-1138. DOI: 10.1177/002204260203200408.Peer-Reviewed Original ResearchInjection drug usersHIV seroprevalenceHIV-seronegative counterpartsHIV-seropositive individualsHIV risk factorsDaily cocaine injectionsDaily heroin injectionDrug use characteristicsHarms of drugsHIV seropositive statusNeedle exchange programsLogistic regression modelsSpeedball injectionHIV antibodiesHIV infectionHeroin injectionProspective studyRisk factorsCocaine injectionFactors AssociatedDrug usersMultivariate modelProgram entryHIVSeroprevalence
1995
Dilated heart muscle disease associated with HIV infection
Herskowitz A, Willoughby S, Vlahov D, Baughman K, Ansari A. Dilated heart muscle disease associated with HIV infection. European Heart Journal 1995, 16: 50-55. PMID: 8682102, DOI: 10.1093/eurheartj/16.suppl_o.50.Peer-Reviewed Original ResearchConceptsHeart muscle diseaseLate-stage HIV infectionCD4 T-cell countGlobal left ventricular dysfunctionT-cell countsLeft ventricular dysfunctionHIV infectionRisk factorsVentricular dysfunctionClinical characteristicsCardiac dysfunctionMuscle diseaseNew York Heart Association class IIILow CD4 T-cell countsSevere global left ventricular dysfunctionCell countAnti-heart antibodiesCardiotropic virus infectionImmunologic risk factorsNon-infectious complicationsPrimary cardiac failureSymptomatic cardiac dysfunctionSymptomatic heart diseaseCongestive heart failureHIV risk factors